Showing results (5441-5450 of 9,342) with videos related to
Sort By:
Pageof 935
Cancer Medicine|September 5, 2025
An Open-Label, Single-Arm, Phase II Trial of Sintilimab Plus Anlotinib for Metastatic Non-Small Cell Lung Cancer After First-Line PD-(L)1 InhibitorXun Shi, Chen Lin, Lishu Lou, et al.Cancer Medicine|September 6, 2025
Impact of Population Pharmacogenomics on Cisplatin-Induced Neurotoxicities in Testicular Cancer SurvivorsSwetha Nakshatri, Paul C Dinh, Lawrence H Einhorn, et al.Cancer Medicine|July 25, 2016
Trends in phase III randomized controlled clinical trials on the treatment of advanced non-small-cell lung cancerCristina Fernández-López, José Expósito-Hernández, Juan Pedro Arrebola-Moreno, et al.Cancer Medicine|July 2, 2015
Epigenetically altered miR-193b targets cyclin D1 in prostate cancerKirsi M Kaukoniemi, Hanna E Rauhala, Mauro Scaravilli, et al.Cancer Medicine|July 3, 2015
Optimal management of cervical cancer in HIV-positive patients: a systematic reviewAtara Ntekim, Oladapo Campbell, Dietrich RothenbacherCancer Medicine|July 29, 2016
A novel hedgehog inhibitor iG2 suppresses tumorigenesis by impairing self-renewal in human bladder cancerLihong Zhu, Chen Ni, Baijun Dong, et al.Cancer Medicine|July 29, 2016
Candidate microRNAs as biomarkers of thyroid carcinoma: a systematic review, meta-analysis, and experimental validationYiren Hu, Hui Wang, Ende Chen, et al.Cancer Medicine|June 26, 2015
Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activityBaohui Liu, Xi Lin, Xiangsheng Yang, et al.Cancer Medicine|June 26, 2015
Discrepancy of target sites between clinician and cytopathological reports in head neck fine needle aspiration: Did I miss the target or did the clinician mistake the organ site?Mahsa Khanlari, Yahya Daneshbod, Hanieh Shaterzadeh Yazdi, et al.Cancer Medicine|August 29, 2025
Cardiomyopathy Screening Adherence Among Medicaid-Enrolled Long-Term Survivors of Childhood CancerXin Hu, Sharon M Castellino, Deo Kumar Srivastava, et al.Pageof 935